J Arthropod-Borne Dis, March 2020, 14(1): 47–55 F Houmansadr et al.: Development of … 47 http://jad.tums.ac.ir Published Online: March 31, 2020 Original Article Development of A Loop-Mediated Isothermal Amplification (LAMP) Assay for Detection of Relapsing Fever Borreliae Faezeh Houmansadr1; *Mohammad Soleimani2,3; *Saied Reza Naddaf4 1 Department of Cellular and Molecular Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran 2 Department of Microbiology, Faculty of Medicine, AJA University of Medical Sciences, Tehran, Iran 3 Tasnim Biotechnology Research Center, Faculty of Medicine, AJA University of Medical Sciences, Tehran, Iran 4 Department of Parasitology, Pasteur Institute of Iran, Tehran, Iran (Received 18 Mar 2019; accepted 04 Mar 2020) Abstract Background: This study aimed to develop a loop-mediated isothermal amplification (LAMP) assay for the rapid detec- tion of tick-borne relapsing fever in resource-limited areas. Methods: A set of six primers were designed based on the conserved regions of the Glycerophosphodiester phos- phodiesterase (glpQ) gene of Borrelia species. For sensitivity assay, serial dilutions of a recombinant plasmid contain- ing a 219bp sequence of the glpQ were prepared and used as the template DNA. The LAMP reactions containing the six primers and the reagents required for amplification were incubated at 60–65 °C for 60min in a Loopamp real-time tur- bidimeter. For the specificity test, DNA from 14 other bacteria were included in the assays, and double-distilled water was used as the negative control. Also, DNA from dried blood spots (DBSs) of spirochetemic mice, and blood samples from relapsing fever-suspected patients were examined by the LAMP along a Borrelia-specific nested PCR that targets the rrs-rrl-IGS region. Results: The LAMP detected as low as 90glpQ copies in reactions. The primers reacted with DNA from DBS of spi- rochetemic mice showing spirochete concentrations of ≤ one per a 1000X microscopic field. In clinical samples, the LAMP assay showed a higher sensitivity compared to nested-PCR. The LAMP specificity was 100%, as the primers did not react with other bacteria DNA. Conclusion: The high sensitivity and specificity of the test, along with the simplicity of the DNA extraction procedure, make the LAMP a reliable and adaptable tool for the diagnosis of tick-borne relapsing fever in rural endemic areas. Keywords: Relapsing fever; Loop-mediated isothermal amplification (LAMP); Iran Introduction The genus Borrelia comprises two distinct groups of spirochetes with the difference in diseases they cause. One group includes the causative agents of Lyme disease and the oth- er the relapsing fever borreliae (RFB). Cur- rently, there are 22 confirmed RFB, and six oth- er taxa have been proposed (1). Except for the louse adapted Borrelia recurrentis, the major- ity of species pathogenic to humans are trans- mitted by the soft ticks of the genus Orni- thodoros. A few species, such as Borrelia miya- motoi and Borrelia lonestari, are vectored by hard ticks and yet share genetic similarities with the RFB (2). Soft tick-borne relapsing fever (STBR) is endemic to Iran (3-5). Until now, de- spite the improvement of housing and the re- moval of the disease from mandatory report- ing to the Ministry of Health and Medical Ed- ucation (MHME), no year has passed without reports of human infections. In Iran, four RFB, including Borrelia persica, Borrelia microti, Borrelia latyschewii and Borrelia baltazardi have been described (5). Borrelia persica is the primary cause of the disease especially in the *Corresponding authors: Dr Mohammad Soleimani, E-mail: soleimanidor@yahoo.com, Dr Saied Reza Nad- daf, E-mail: saiedrezanaddaf@gmail.com http://jad.tums.ac.ir/ J Arthropod-Borne Dis, March 2020, 14(1): 47–55 F Houmansadr et al.: Development of … 48 http://jad.tums.ac.ir Published Online: March 31, 2020 west and northwest of the country (5-7), while in the south, epidemiological data and molec- ular approved human infections indicated B. microti and other B. microti-like borreliae as the other cause of relapsing fever (3, 8, 9). In Iran, until recently, confirmation of re- lapsing fever merely relied on observation of the spirochetes in peripheral blood of febrile patients using darkfield microscopy or Giem- sa-stained blood smears. The disease is easily diagnosed by microscopy during fever peaks with a massive spirochetemia. However, be- tween the peaks and in milder diseases, the bacteria are scanty and are hard to identify in blood smears. In Iran, PCR assays using vari- ous molecular markers like flaB, glpQ and rrs have successfully detected the Borrelia spp in relapsing fever patients (3, 8) and animals (10). The PCR assays exhibit high sensitivities but are not commonly affordable in resource-lim- ited laboratories of rural areas, where most of the relapsing fever infections occur. Hence, we prompted to develop an alternative DNA amplification assay of lower cost for the de- tection of the disease in these areas. Loop-me- diated isothermal amplification (LAMP) has proved as a robust, cheap, highly sensitive/ specific tool for the detection of various path- ogenic agents including viruses, bacteria, fun- gi, and parasites (11-14). This assay employs a DNA polymerase and a set of 4–6 primers that operate in isothermal conditions forming loop structures that ultimately precipitate in the reaction mixture (13). This assay has also shown to be less prone to inhibition from DNA preparations and allows adaptability to field conditions (15, 16). This study aimed to develop a (LAMP) as- say for the rapid detection of relapsing fever borreliae based on the glycerophosphodiester phosphodiesterase (glpQ) gene, a sequence con- served among all relapsing fever borreliae, but absent from Lyme disease spirochetes (17). Materials and Methods Bacteria species and DNA extraction We used B. microti strain IR-1, which was maintained via continual passages in NMRI mice for more than 15 years in the Parasitol- ogy Department of Pasteur Institute of Iran. Blood samples were obtained from B. microti- infected mice when spirochetes reached 1.4× 106/ml of blood. DNA extraction from 1ml of blood was performed using a Genomic DNA Purification Kit (Promega, Madison, USA) as described by the manufacturer. Primer design Initially, glpQ sequences of 10 relapsing fever Borreliae (B. microti, Acc. No. JF825473; B. microti, Acc. No. EU914144; B. recurren- tis, Acc. No. KJ003842, Borrelia sp., Acc. No. KX683865; Borrelia duttonii, Acc. No. DQ 346785; Borrelia crocidurae, Acc. No. CP 004267; Borrelia hispanica; Acc. No. GU 357573; B. persica, Acc. No. EU914143; B. recurrentis, Acc. No. AF247152; Borrelia dut- tonii, Acc. No. GU357577) were obtained from the GenBank database and aligned by using CLC Sequence Viewer 7 (CLC bio, Aarhus, Denmark). A set of six primers including two loop primers were designed based on the con- served regions of the glpQ sequence, corre- sponding to the nucleotides 261015–261682 of B. duttonii strain Ly (Fig. 1), by the online software program, Primer Explorer V4 (Eiken Chemical Co., Tokyo, Japan; http://primerexplorer.jp/e/). The theoretical specificity of the designed primers was con- firmed by in silico analysis using BLAST and Primer-BLAST software available in NCBI (http://www. ncbi.nlm.nih.gov/). The primers were synthesized by a commercial company (Generay Biotechnology, Shanghai, China). The main primers (glpQ-F3 and glpQ-B3) and (glpQ-FIP and glpQ-BIP) target fragments of 219bp and 161bp size, respectively, and the loop primer (glpQ-LF and glpQ-LB) produce http://jad.tums.ac.ir/ J Arthropod-Borne Dis, March 2020, 14(1): 47–55 F Houmansadr et al.: Development of … 49 http://jad.tums.ac.ir Published Online: March 31, 2020 amplicons of various size with a ladder-like pattern (Table 1). Glycerophosphodiester Phosphodiesterase Gene (glpQ) cloning A 219bp fragment of the glpQ gene was amplified by the primers glpQ-F3 and glpQ- B3 (Table 1). The reaction contained 3mM MgSO4 (Biobasic, Toronto, Canada), 1.6mM dNTPs (Kawsar Biotech Co, Tehran, Iran), 1µl 10X buffer [100mM KCl, 100mM (NH4)2SO4, 200mM Tris HCl (pH 8.75)], 1% Triton X-100, 1mg/ml BSA (Biobasic, Toronto, Canada), 1U Taq DNA Polymerase (Biobasic, Toronto, Can- ada), 0.4µM of each primer, 1µl template DNA, and double-distilled water (DDW) to the 25µl final volume. The amplification was pro- grammed in a thermal cycler (Eppendorf, Ham- burg, Germany), for an initial denaturation at 94 oC for 4min followed by 35 cycles of 94 oC for 45sec, 45 oC for 45sec, and 72 oC for 30sec, and a final extension at 72 oC for 10min. The PCR products were run on a 2% agarose gel (Min Run Gel Electrophoresis System; Bio- Equip co, Shanghai, China), stained with eth- idium bromide (CinnaGen, Alborz, Iran), and visualized under UV in Gel Documentation system (E-BOX VILBER, Marne-la-Vallée, France). The PCR product was purified using a PCR Purification Kit (Bioneer, Daejeon, South Korea), cloned into a TA vector (In- sTAclone™ PCR Cloning Kit, Thermo Scien- tific, MA, United States), and transformed in Escherichia coli Top10F’. The bacteria were incubated at 37 °C for 24h on Luria-Bertani medium (Merck, KGaA, Darmstadt, Germa- ny) containing 24mg/ml IPTG (isopropyl-beta- D-thiogalactopyranoside) (Fermentas, Ontario, Canada), 20mg/ml X-gal (5-bromo-4-chloro- 3-indolyl beta d-galactoside) (Fermentas, On- tario, Canada), 10mg/ml tetracycline (Razak, Alborz, Iran) and 50mg/ml ampicillin (Cosar, Tehran, Iran). The recombinant bacteria were identified by blue/white screening, with the while colonies representing recombinant ones. One white colony was added to Luria-Bertani broth medium containing 10mg/ml tetracy- cline and 50mg/ml ampicillin followed by in- cubation at 37 °C for 16h while shaking at 180 RPM. Plasmid purification was performed by the AccuPrep Plasmid Mini Extraction kit (Bioneer, Daejeon, South Korea) and the pres- ence of the glpQ gene in the recombinant plas- mids was confirmed by PCR amplification with the primers glpQ-F3 and glpQ-B3. The recom- binant plasmid was named pTZ57R/T-glpQ. Sensitivity assay A serial 10-fold dilution of the recombi- nant plasmid ranging from 9×108 to 9×10-1 copy numbers per microliter, equivalent to ≈32ng to ≈32×104 fg/µl of DNA was prepared and used in assays. Specificity assay For specificity assays, we used DNA of 14 other bacteria including Shigella sonnei ATCC 9290, Klebsiella pneumoniae ATCC 7881, Ba- cillus subtilis ATCC 6051, Staphylococcus aureus ATCC 25923, Enterococcus faecalis ATCC 29212, Enteropathogenic Escherichia coli (EPEC) ATCC 43887, Yersinia entero- colitica ATCC 23715, Pseudomonas aerugino- sa ATCC 27853, clinical specimens of Esche- richia coli, Salmonella typhi, Acinetobacter baumannii, Citrobacter sp, Enterobacter sp, and Leptospira interrogans in all assays. All the bacteria, including L. interrogans, the close- ly related bacteria to Borrelia species con- tained glpQ sequence. Loop Mediated Isothermal Amplification (LAMP) assay The LAMP reactions contained 40pM of the inner (glpQ-FIP and glpQ-BIP) and 10pM of outer (glpQ-F3 and glpQ-B3) and loop pri- mers (glpQ-LF and glpQ-LB) (Table 1), 11.2 mM dNTPs (Kawsar Biotech Co, Tehran, Iran), 0.8M betaine (Sigma Aldrich, Taufkirchen, Germany), 20mM Tris-HCl, 10mM KCl, 10mM (NH2)SO4, 0.05% Triton X-100 (pH 8.8) (Bi- olabs, New England, UK), 8mM MgSo4 (Bi- http://jad.tums.ac.ir/ J Arthropod-Borne Dis, March 2020, 14(1): 47–55 F Houmansadr et al.: Development of … 50 http://jad.tums.ac.ir Published Online: March 31, 2020 obasic, Toronto, Canada), 0.1% Tween 20 (Acros Organics, Vernon, USA), 8U of Bst DNA polymerase, large fragment (Biolabs, New England, UK), 1μl of serial dilutions of the recombinant plasmid, and DDW to the 25 μl final volume. The reactions were incubated at temperatures ranging from 60–65 °C for 60min in a Loopamp real-time turbidimeter (LA-320C; Teramecs, Kyoto, Japan), followed by heating at 80 °C for 5min for enzyme in- activation. In all assays, DNAs from 14 other bacteria were included and DDW was used as a negative control. During the optimization of the assay, some amplifications were performed without the loop primers. Also, in some reactions, we added 1μl of Fluorescent detection reagent contain- ing Calcein (Eiken Chemical co., Tokyo, Ja- pan), an indicator of DNA amplification. Detection of LAMP products The amplification in LAMP reactions was examined by 1) naked eye observation of white turbidity resulting from the accumulation of magnesium pyrophosphate, a by-product of the reactions, 2) a Loopamp real-time turbi- dimeter that records the optical density of re- actions every 6sec at 650nm (the reactions were considered positive when the turbidity reached ≥ 0.1 within 60min), 3) the color change from orange to green, as an indication of DNA am- plification, and 4) gel electrophoresis of am- plicons on 2% agarose gels. A LAMP product resulting from the 9×108 dilution was purified using PCR Purification Kit (Bioneer, Daejeon, Korea) and sequenced in both directions by (ABI 3730xl/Bioneer 3730xl, Daejeon, Republic of Korea). Preparation of DBSs from Borrelia-infected mice Amounts of 200µl blood from B. microti- infected mice with various degrees of the spi- rochetemia (225±61.34, 71±36.71, 3.3±1.63, 1.1±1.44, and 0.8±0.78 spirochetes per micro- scopic field) were dotted on 30 DNA banking cards (DBC) (Kawsar Biotech Co, Tehran, Iran). Blood from non-infected mice was used as controls on DBCs. The blood spots were al- lowed to dry at room temperature, and the DBCs were kept in the same condition until used. Loop Mediated Isothermal Amplification (LAMP) and PCR with DBS Circles of 2mm from DBSs were cut and washed three times with DNA extraction buff- er (provided by the manufacturer), followed by DDW. The circles were allowed to dry at room temperature and then used in LAMP and PCR assays as described above except that instead of template DNA, DBS circles were in- cluded in the reactions. The sensitivity and specificity of the LAMP assay were calculated in comparison with mi- croscopy as the gold standard assay using Med- Calc (2018 MedCalc Software bvba) software available online (https://www.medcalc.org/calc/diagnostic_tes t.php). Loop Mediated Isothermal Amplification (LAMP) and nested-PCR amplification of clinical specimens DNA was extracted from 39 sera of febrile patients residing in the relapsing fever en- demic areas in the south and west of Iran us- ing a commercial DNA extraction kit as de- scribed above. The DNA samples were exam- ined by the LAMP, and a Borrelia-specific nested PCR that amplifies the rrs-rrl-IGS re- gion using the outer primers F, 5´-GTATG TTTAGTGAGGGGGGTG-3´ and R, 5´-GG ATCATAGCTCAGGTGGTTAG-3 ́ and inner nested primers F, 5´-AGGGGGGTGAAGTC GTAACAAG-3 ́and R, 5 -́GTCTGATAAACC TGAGGTCGGA-3´ (18). This PCR has exhib- ited high sensitivity in detecting relapsing fe- ver borreliae (3, 8, 19, 20). In all assays, for spec- ificity test, DNAs from other bacteria species were included and DDW was used as a negative control. The LAMP reactions were checked for DNA amplification as described above, and the http://jad.tums.ac.ir/ J Arthropod-Borne Dis, March 2020, 14(1): 47–55 F Houmansadr et al.: Development of … 51 http://jad.tums.ac.ir Published Online: March 31, 2020 PCR products were resolved on 2% agarose gels, visualized under UV and photographed. Results Glycerophosphodiester Phosphodiesterase Gene (glpQ ) cloning Amplification of the glpQ sequence from the recombinant plasmid (pTZ57R/T-glpQ) with the primers glpQ-F3 and glpQ-B3yielded the ex- pected 219bp indicating the insertion of this sequence in the plasmid. Loop Mediated Isothermal Amplification (LAMP) assay with recombinant pTZ57R/ T-glpQ We observed amplification of glpQ sequence in the LAMP reactions by naked eye observa- tion of turbidity and the Loopamp real-time tur- bidimeter down to 9×103 copies of recombi- nant plasmid equivalent to 0.32fg DNA (Fig. 2A). However, gel electrophoresis revealed am- plifications in two lower dilutions of 9×102 and 9×101, equivalent to 3.2fg and 0.32fg DNA, respectively (Fig. 2B). Our LAMP assay was 100% specific as the primers reacted with none of the other 14 bacterial DNA, including L. in- trogans. In the reactions containing calcein and the Borrelia DNA, the color turned from or- ange to green. The 137bp sequence resulted following the sequencing of the LAMP amplicon matched with the glpQ sequence of B. microti strain IR-1 (acc. No. JF825473) corresponding to nucleo- tides 261158–261295 of the whole genome sequence of B. duttonii Ly (acc. No. CP000796). The results were the same within the tempera- ture range of 60–65 °C. In the reactions, in ab- scence of loop primers, the optimum time for isothermal amplification was 60min, whereas, in those with the loop primers, the incubation time reduced to 45min. Loop Mediated Isothermal Amplification (LAMP) and PCR with DBSs Of the 30 B. microti-positive DBS, all (100%) showed turbidity with the naked eye indicating amplification, while the glpQ-PCR (with the primers glpQ-F3 and glpQ-B3) yielded the ex- pected 219bp band in 20 positive DBSs (66.67 %). The negative PCR reactions belonged to the mice with the lowest level of spirochetemia [1.1±1.44 (n= 4) and 0.8±0.78 (n= 6) spiro- chete per microscopic field]. Neither LAMP nor PCR amplification was observed with the negative controls (DDW) or reactions contain- ing other bacteria DNA as the template. By considering microscopy as the gold stand- ard, the sensitivity of glpQ-LAMP and glpQ- PCR were 100% and 66.67%, respectively. The specificity was 100% for both assays. Loop Mediated Isothermal Amplification (LAMP) and PCR with clinical samples Of 39 clinical samples, 11 became turbid in the LAMP assay indicating amplification of glpQ gene, whereas PCR amplification of IGS sequence only yielded the expected 540bp band in three specimens (Fig. 3). Table 1. The primers designed and used for amplification of glpQ gene by LAMP assay Primers Name Sequences (5' to 3') glpQ-F3 Forward outer primer AATGCACGATCCTGAACT glpQ-B3 Backward outer primer TCTTCTTCTAGGGTTGGAATT glpQ-FIP Forward inner primer TGCTAATGTGAAATCGACGGAATAA- CAACAACAAATGTTGCAAAGC glpQ-BIP Backward inner primer AATCACTAAGCCTTAGCGAAAGAT- TGTTGCAGGAAAACGGTTA glpQ-LF Forward loop primer TCTCTAGCTCTTCCTGGAAACA glpQ-LB Backward loop primer CCTGAAACACAACAACCAATATACC http://jad.tums.ac.ir/ J Arthropod-Borne Dis, March 2020, 14(1): 47–55 F Houmansadr et al.: Development of … 52 http://jad.tums.ac.ir Published Online: March 31, 2020 Fig. 1. The regions of the glpQ from which the primers designed for LAMP assay. Forward outer primer, glpQ-F3; backward outer primer, glpQ-B3; forward inner primer, glpQ-FIP (F2)+glpQ-FIP (FIc); backward inner primer, glpQ- BIP (B2)+glpQ-BIP (BIc); forward loop primer, glpQ-LF; backward loop primer, glpQ-LB Fig. 2. The sensitivity of the Loop Mediated Isother- mal Amplification (LAMP) assay measured by a 10- fold serial dilution of a recombinant plasmid pTZ57R/T-glpQ plasmid ranging from 9×109 to 9×10- 1/µl. A) The amplification curves generated by the Loopamp real-time turbidimeter, colored lines 1–7, serial dilutions 9×109, 9×108, 9×107, 9×106, 9×105, 9×104 and 9×103; line 8, serial dilutions ≤ 9×102. B) the LAMP products resolved on agarose gel, lane M, 50bp DNA ladder, lane 1, dilution 9×109; lane 2, dilu- tion 9×108; lane 3, dilution 9×107; lane 4, dilution 9×106; lane 5, dilution 9×105; lane 6, dilution 9×104; lane 7, dilution 9×103; lane 8, dilution 9×102; lane 9, dilution 9×101; lane 10, dilution 9×100; lane 11, dilu- tion 9×10-1; lane 12, negative control Fig. 3. Gel electrophoresis of PCR amplification of the rrs-rrl-IGS region. Lane M, 5bp DNA ladder; lanes 1– 6, human blood samples (a 540bp in lanes 4 and 5 indi- cates amplification of Borrelia DNA); lane 7, negative control (DDW) Discussion In Iran, blood analysis of relapsing fever patients by examination of wet smears using dark-field microscopy or Giemsa-stained blood slides has been a common practice for years. This approach was efficient in endemic areas, where the disease commonly appeared in clus- http://jad.tums.ac.ir/ J Arthropod-Borne Dis, March 2020, 14(1): 47–55 F Houmansadr et al.: Development of … 53 http://jad.tums.ac.ir Published Online: March 31, 2020 ters (5), and overlooking the spirochetes in the blood of some febrile patients did not ques- tion the identity of the causative agent. How- ever, with the decline of the disease in the en- demic regions and reports of sporadic cases from other areas application of more sensitive ap- proaches for the identification RFB became necessary. In Iran, over the past decade, PCR assays by based on various molecular mark- ers, such as glpQ, rrs, and flaB, were devel- oped for the identification of Borrelia infec- tion in Ornithodoros ticks (21, 22) or charac- terization of the tick-originated relapsing fe- ver borreliae (9, 23), but rarely clinical sam- ples were included. Lately, qPCR and con- ventional PCRs identified a B. microti-like strain, presumably, an ecotype of African B. duttonii, in relapsing fever patients from southern Iran (3, 8). In our previous work, using B. persica-spiked blood samples, we consistently observed bacte- ria by microscopy in the blood samples with densities ≥ 800–1000 spirochetes/µl (24). Here- in, with the DBSs prepared with the spiro- chetemic murine blood, the LAMP could de- tect borrelial DNA in blood specimens show- ing less than one spirochetes per 1000X mi- croscopic field. Our LAMP assay also showed a higher sensitivity in comparison with a nest- ed-PCR amplification of the IGS in the diag- nosis of clinical samples. The specificity of the LAMP assay for the diagnosis of B. microti DNA was 100% as the designed primers exhib- ited no cross-reaction with DNA from the oth- er 14 bacteria used in this study. Our LAMP method requires to be further tested with blood samples from RF patients infected with other Borrelia species to ensure the sensitivity and specificity of the assay. LAMP method has also shown promise for the detection of borreliae DNA and other path- ogens in the tick vectors. In China, the LAMP could detect B. burgdorferi s. l. in ticks, with a higher sensitivity than a conventional PCR (25). Also, in recognizing spotted fever group rickettsia, the LAMP appeared ten times more sensitive than an end-point PCR targeting the same gene fragment (26). Conclusion Such a reliable sensitivity and specificity, as well as the simplicity of the DNA extrac- tion procedure, make the LAMP a suitable and adaptable assay for field studies in relapsing fever endemic areas. In resource-limited rural health centers, LAMP can readily check field- collected blood samples, preferably on DBS, for relapsing fever borreliae with the least equipment accessible, i.e., a heat block. Hav- ing access to a Loopamp real-time turbidim- eter is preferable. However, LAMP is a qual- itative assay, and the result can also be moni- tored by color change with calcein in the fluo- rescent detection reagent or by the turbidity of magnesium pyrophosphate in the reaction tubes. Hence, a heating system that provides a temperature within the range of 60–65 °C would suffice. Acknowledgements We thank the Tasnim Biotechnology of Research Center (TBRC), AJA University of Medical Sciences, for their technical support. The authors declare that there is no conflict of interest. References 1. Talagrand-Reboul E, Boyer PH, Bergstrom S, Vial L, Boulanger N (2018) Relaps- ing Fevers: Neglected Tick-Borne Dis- eases. Front Cell Infect Microbiol. 8: 98. 2. Cutler SJ (2015) Relapsing Fever Borreli- ae: A Global Review. Clin Lab Med. 35 (4): 847–865. 3. Naddaf SR, Ghazinezhad B, Sedaghat MM, Asl HM, Cutler SJ (2015) Tickborne re- http://jad.tums.ac.ir/ J Arthropod-Borne Dis, March 2020, 14(1): 47–55 F Houmansadr et al.: Development of … 54 http://jad.tums.ac.ir Published Online: March 31, 2020 lapsing fever in southern Iran, 2011–2013. Emerg Infect Dis. 21(6): 1078–1080. 4. Masoumi Asl H, Goya MM, Vatandoost H, Zahraei SM, Mafi M, Asmar M, Piazak N, Aghighi Z (2009) The epidemiology of tick-borne relapsing fever in Iran dur- ing 1997–2006. Travel Med Infect Dis. 7(3): 160–164. 5. Karimi U (1981) Relapsing Fever and its Epidemiology. Pasteur Institute of Iran Press, Tehran (In Persian). 6. Karimi Y, Hovind-Hougen K, Birch-Ander- sen A, Asmar M (1979) Borrelia persica and B. baltazardi sp. nov.: experimental pathogenicity for some animals and com- parison of the ultrastructure. Ann Micro- biol (Paris). 130B(2): 157–168. 7. Karimi Y, Hannoun C, Ardouin P, Ameli M (1976) Sur le purpura he'morragique observe 'dans l'Azerbaidjan-Est de l'Iran. Me'd Mal Infec. 6: 399–404. 8. Naddaf SR, Ghazinezhad B, Kazemirad E, Cutler SJ (2017) Relapsing fever causa- tive agent in Southern Iran is a closely related species to East African borreliae. Ticks Tick-Borne Dis. 8(6): 882–886. 9. Naddaf SR, Ghazinezhad B, Bahramali G, Cutler SJ (2012) Phylogenetic analysis of the spirochete Borrelia microti, a potential agent of relapsing fever in Iran. J Clin Microbiol. 50(9): 2873–2876. 10. Shirani D, Rakhshanpoor A, Cutler SJ Ghazinezhad B, Naddaf SR (2016) A case of canine borreliosis in Iran caused by Borrelia persica. Ticks Tick Borne Dis. 7(3): 424–426. 11. Han F, Ge B (2010) Quantitative detection of Vibrio vulnificus in raw oysters by real-time loop-mediated isothermal am- plification. Int J Food Microbiol. 142 (1): 60–66. 12. McKenna JP, Fairley DJ, Shields MD, Cosby SL, Wyatt DE, McCaughey C, Coyle PV (2011) Development and clinical valida- tion of a loop-mediated isothermal am- plification method for the rapid detection of Neisseria meningitidis. Diagn Micro- biol Infect Dis. 69(2): 137–144. 13. Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, Hase T (2000) Loop-mediated isother- mal amplification of DNA. Nucleic Acids Res. 28(12): e63. 14. Mansour SM, Ali H, Chase CC, Cepica A (2015) Loop-mediated isothermal ampli- fication for diagnosis of 18 World Or- ganization for Animal Health (OIE) no- tifiable viral diseases of ruminants, swine and poultry. Anim Health Res Rev. 16(2): 89–106. 15. Caipang CMA, Haraguchi I, Ohira T, Hi- rono I, Aoki T (2004) Rapid detection of a fish iridovirus using loop-mediated isothermal amplification (LAMP). J Virol Methods. 121(2): 155–161. 16. Mori Y, Notomi T (2009) Loop-mediated isothermal amplification (LAMP): a rapid, accurate, and cost-effective diagnostic method for infectious diseases. J Infect Chemother. 15(2): 62–69. 17. Schwan TG, Schrumpf ME, Hinnebusch BJ, Anderson DE, Jr, Konkel ME (1996) GlpQ: an antigen for serological dis- crimination between relapsing fever and Lyme borreliosis. J Clin Microbiol. 34 (10): 2483–2492. 18. Bunikis J, Garpmo U, Tsao J, Berglund J, Fish D, Barbour AG (2004) Sequence typing reveals extensive strain diversity of the Lyme borreliosis agents Borrelia burgdorferi in North America and Bor- relia afzelii in Europe. Microbiology. 150(Pt 6): 1741–1755. 19 . Scott JC, Wright DJM, Cutler JC (2005) Typing African relapsing fever spiro- chetes. Emerg Infect Dis. 11(11): 1722– 1729. 20. Cutler SJ, Bonilla EM, Singh RJ (2010) Population structure of East African re- lapsing fever Borrelia spp. Emerg Infect http://jad.tums.ac.ir/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC102748/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC102748/ https://www.ncbi.nlm.nih.gov/pubmed/?term=Bunikis%20J%5BAuthor%5D&cauthor=true&cauthor_uid=15184561 https://www.ncbi.nlm.nih.gov/pubmed/?term=Garpmo%20U%5BAuthor%5D&cauthor=true&cauthor_uid=15184561 https://www.ncbi.nlm.nih.gov/pubmed/?term=Tsao%20J%5BAuthor%5D&cauthor=true&cauthor_uid=15184561 https://www.ncbi.nlm.nih.gov/pubmed/?term=Berglund%20J%5BAuthor%5D&cauthor=true&cauthor_uid=15184561 https://www.ncbi.nlm.nih.gov/pubmed/?term=Berglund%20J%5BAuthor%5D&cauthor=true&cauthor_uid=15184561 https://www.ncbi.nlm.nih.gov/pubmed/?term=Fish%20D%5BAuthor%5D&cauthor=true&cauthor_uid=15184561 https://www.ncbi.nlm.nih.gov/pubmed/?term=Barbour%20AG%5BAuthor%5D&cauthor=true&cauthor_uid=15184561 J Arthropod-Borne Dis, March 2020, 14(1): 47–55 F Houmansadr et al.: Development of … 55 http://jad.tums.ac.ir Published Online: March 31, 2020 Dis. 16(7): 1076–1080. 21. Rafinejad J, Choubdar N, Oshaghi M, Piazak N, Satvat T, Mohtarami F, Barmaki A (2011) Detection of Borrelia persica In- fection in Ornithodoros tholozani Using PCR Targeting rrs Gene and Xenodiag- nosis. Iran J Public Health. 40(4): 138– 145. 22. Barmaki A, Rafinejad J, Vatandoost H, Telmadarraiy Z, Mohtarami F, Leghaei Sh, Oshaghi M (2010) Study on Pres- ence of Borrelia persica in Soft Ticks in Western Iran. Iran J Arthropod Borne Dis. 4 (2): 19–25. 23. Oshaghi MA, Rafinejad J, Choubdar N, Piazak N, Vatandoost H, Telmadarraiy Z, Mohtarami F, Ravasan NM (2011) Discrimination of relapsing fever Borre- lia persica and Borrelia microtti by di- agnostic species-specific primers and pol- ymerase chain reaction-restriction frag- ment length polymorphism. Vector Borne Zoonotic Dis. 11 (3): 201–207. 24. Naddaf SR, Kishdehi M, Siavashi M (2011) Comparison of PCR-Based Diagnosis with Centrifuged-Based Enrichment Method for Detection of Borrelia persica in An- imal Blood Samples. Iran J Arthropod Borne Dis. 5(1): 7–12. 25. Yang J, Guan G, Niu Q, Liu Z, Li Y, Liu J, Ma M, Ren Q, Liu A, Yin H (2013) Development and application of a loop- mediated isothermal amplification assay for rapid detection of Borrelia burgdor- feri s. l. in ticks. Transbound Emerg Dis. 60(3): 238–244. 26. Noden BH, Martin J, Carrillo Y, Talley JL, Ochoa-Corona FM (2018) Development of a loop-mediated isothermal amplifi- cation (LAMP) assay for rapid screen- ing of ticks and fleas for spotted fever group rickettsia. PLoS One. 13(2): e0192331. http://jad.tums.ac.ir/ https://www.ncbi.nlm.nih.gov/pubmed/?term=Barmaki%20A%5BAuthor%5D&cauthor=true&cauthor_uid=22808396 https://www.ncbi.nlm.nih.gov/pubmed/?term=Rafinejad%20J%5BAuthor%5D&cauthor=true&cauthor_uid=22808396 https://www.ncbi.nlm.nih.gov/pubmed/?term=Vatandoost%20H%5BAuthor%5D&cauthor=true&cauthor_uid=22808396 https://www.ncbi.nlm.nih.gov/pubmed/?term=Vatandoost%20H%5BAuthor%5D&cauthor=true&cauthor_uid=22808396 https://www.ncbi.nlm.nih.gov/pubmed/?term=Telmadarraiy%20Z%5BAuthor%5D&cauthor=true&cauthor_uid=22808396 https://www.ncbi.nlm.nih.gov/pubmed/?term=Mohtarami%20F%5BAuthor%5D&cauthor=true&cauthor_uid=22808396 https://www.ncbi.nlm.nih.gov/pubmed/?term=Leghaei%20Sh%5BAuthor%5D&cauthor=true&cauthor_uid=22808396 https://www.ncbi.nlm.nih.gov/pubmed/?term=Leghaei%20Sh%5BAuthor%5D&cauthor=true&cauthor_uid=22808396 https://www.ncbi.nlm.nih.gov/pubmed/?term=Oshaghi%20M%5BAuthor%5D&cauthor=true&cauthor_uid=22808396